CVS will close 270 more stores by 2025 to streamline operations, sparking concerns over reduced pharmacy access in vulnerable ...

CVS is reportedly offering staff rewards like bonuses and pizza parties to increase vaccination rates, amid slowing demand ...

News that Rite Aid is sell off its assets amid a bankruptcy doesn’t mean shuttered brick-and-mortar stores will re-open under a CVS Health or Walgreens banner.

The company’s new transformation strategy, called Celebrations Wave, aims to increase revenues across both every day and holiday occasions, optimize operations, lower costs and accelerate the pace of ...

The move comes as the automaker braces for steep U.S. tariffs and an anticipated 26% drop in American sales. CEO Takao Kato revealed the early-stage plans while announcing the company’s financial ...

Netflix and YouTube – have hewed to the decades-old strategy of huge New York bashes. But Paramount, after a restructuring of its ad sales group, decided to shift gears after its 60 Minutes ...

A two-part communication strategy that included discussing vaccine concerns with skeptical parents was not effective in boosting immunization among their children, according to a new study ...

Management reaffirmed 2025 guidance for net sales growth of 3% to 5% and adjusted diluted EPS in the range of $7.55 to $7.85. This guidance does not factor in potential impacts from new tariffs or ...

While sales of its COVID-19 vaccine continue to decline as expected in a post-pandemic market, Moderna is taking proactive steps to reshape its future. The company is swiftly advancing multiple ...

The only segment to decline was commercial vehicles, where sales dropped by 1.05% to 90,558 ... Nonetheless, the bus segment within CVs remained strong, fuelled by institutional demand from ...

PPG reports that its Performance Coatings segment Q1 organic sales increased by 9% with price and sales volume improvements. Chairman and CEO Tim Kenevich said during the company’s Q1 earnings ...

Novavax is recognized for its expertise in vaccine science, focusing on protein-based nanoparticles and adjuvants. The company’s growth strategy revolves around diversifying partnerships by out ...